Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models-Reference-Cited by-同舟云学术

Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models

Published:2022-01 Issue: Volume:288 Page:120166
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Karoon Kiani Fariba,Izadi Sepideh,Ansari Dezfouli Ehsan,Ebrahimi Farbod,Mohammadi Mohammad,Chalajour Hengameh,Mortazavi Bulus Mirmohammad,Nasr Esfahani Maryam,Karpisheh Vahid,Mahmoud Salehi Khesht Armin,Abbaszadeh-Goudarzi Kazem,Soleimani Ali,Gholizadeh Navashenaq Jamshid,Ahmadi Majid,Hassannia Hadi,Hojjat-Farsangi Mohammad,Shahmohammadi Farid Sima,Hashemi Vida,Jadidi-Niaragh Farhad

Funder

Tabriz University of Medical Sciences

Arak University of Medical Sciences

National Institute for Medical Research Development

Iran National Science Foundation

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference82 articles.

1. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice;Jadidi-Niaragh;J. Control. Release,2017

2. Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18;Roeven;J. Immunother.,2015